David Englert
Technik-/Wissenschafts-/F&E-Leiter bei Axela, Inc.
Profil
David Englert is currently the Head of Research & Development at Axela, Inc. He previously worked as a Researcher at Pharmacia LKB Biotechnology, Inc. Dr. Englert holds a doctorate degree from The State University of New York.
Aktive Positionen von David Englert
| Unternehmen | Position | Beginn |
|---|---|---|
Axela, Inc.
 Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 30.08.2011 |
Ehemalige bekannte Positionen von David Englert
| Unternehmen | Position | Ende |
|---|---|---|
| Pharmacia LKB Biotechnology, Inc. | Corporate Officer/Principal | - |
Ausbildung von David Englert
| The State University of New York | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Axela, Inc.
Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Health Technology |
| Pharmacia LKB Biotechnology, Inc. |
